论文部分内容阅读
目的:讨论食管癌根治性术后辅助放化疗临床疗效观。方法:选取2011年9月至2016年1月,38例患有食管癌的患者为研究对象,所有患者均实施术后辅助放化疗治疗。结果:在不良反应情况方面,患者常见的不良反应为消化道损伤,其次为呼吸道损伤、白细胞下降、贫血、血红蛋白下降以及血小板减少等,并且对换实施为期一年的随访,患者的生存人数为30例,占78.95%,出现复发的患者为13例,复发率为34.21%。结论:术后辅助放化疗可以有效的保障治疗效果,增加患者的生存率,但是会给患者带来一系列不良反应。
Objective: To discuss the clinical effect of adjuvant radiochemotherapy after radical operation of esophageal cancer. Methods: From September 2011 to January 2016, 38 patients with esophageal cancer were selected as study subjects. All patients underwent adjuvant chemoradiotherapy after operation. Results: In the aspect of adverse reactions, the common adverse reactions were gastrointestinal tract injury, followed by respiratory tract injury, leukopenia, anemia, hemoglobin decline and thrombocytopenia, and the one-year follow-up of exchange was implemented. The number of patients surviving was 30 cases, accounting for 78.95%, recurrence in 13 patients, the recurrence rate was 34.21%. Conclusion: Postoperative adjuvant chemoradiotherapy can effectively protect the treatment effect and increase the survival rate of patients, but it will bring a series of adverse reactions to the patients.